Literature DB >> 23852824

Combined deficiency of coagulation factors V and VIII: an update.

Chunlei Zheng1, Bin Zhang.   

Abstract

Combined deficiency of factor V (FV) and FVIII (F5F8D) is an autosomal recessive bleeding disorder characterized by simultaneous decreases of both coagulation factors. This review summarizes recent reports on the clinical presentations, treatments, and molecular mechanism of F5F8D. Genetic studies identified LMAN1 and MCFD2 as causative genes for this disorder, revealing a previously unknown intracellular transport pathway shared by the two important blood coagulation factors. LMAN1 and MCFD2 form a Ca2+-dependent cargo receptor complex that functions in the transport of FV/FVIII from the endoplasmic reticulum (ER) to the Golgi. Disrupting the LMAN1-MCFD2 receptor, complex formation is the primary molecular defect of missense mutations leading to F5F8D. The EF-hand domains of MCFD2 are necessary and sufficient for the interactions with both LMAN1 and FV/FVIII. Similarly, the carbohydrate recognition domain of LMAN1 contains distinct and separable binding sites for both MCFD2 and FV/FVIII. Therefore, FV and FVIII likely carry duel sorting signals that are separately recognized by LMAN1 and MCFD2 and necessary for the efficient ER-to-Golgi transport. FV and FVIII likely bind LMAN1 through the high-mannose N-linked glycans under the higher Ca2+ conditions in the ER and dissociate in the lower Ca2+ environment of the ER-Golgi intermediate compartment. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852824      PMCID: PMC4446966          DOI: 10.1055/s-0033-1349223

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  57 in total

1.  Successful use of recombinant FVIIa in combined factor V and FVIII deficiency with surgical bleeding resistant to substitutive treatment. A case report.

Authors:  I Di Marzio; O Iuliani; R Malizia; G Rolandi; S Sanna; G Castaman; A Dragani
Journal:  Haemophilia       Date:  2011-01       Impact factor: 4.287

2.  Sar1p N-terminal helix initiates membrane curvature and completes the fission of a COPII vesicle.

Authors:  Marcus C S Lee; Lelio Orci; Susan Hamamoto; Eugene Futai; Mariella Ravazzola; Randy Schekman
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

3.  Cargo selectivity of the ERGIC-53/MCFD2 transport receptor complex.

Authors:  Beat Nyfeler; Bin Zhang; David Ginsburg; Randal J Kaufman; Hans-Peter Hauri
Journal:  Traffic       Date:  2006-10-01       Impact factor: 6.215

4.  Structural basis for the cooperative interplay between the two causative gene products of combined factor V and factor VIII deficiency.

Authors:  Miho Nishio; Yukiko Kamiya; Tsunehiro Mizushima; Soichi Wakatsuki; Hiroaki Sasakawa; Kazuo Yamamoto; Susumu Uchiyama; Masanori Noda; Adam R McKay; Kiichi Fukui; Hans-Peter Hauri; Koichi Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

5.  Stent thrombosis is associated with an impaired response to antiplatelet therapy.

Authors:  Peter Wenaweser; Janine Dörffler-Melly; Katja Imboden; Stephan Windecker; Mario Togni; Bernhard Meier; Andre Haeberli; Otto M Hess
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

6.  Crystal structure of the LMAN1-CRD/MCFD2 transport receptor complex provides insight into combined deficiency of factor V and factor VIII.

Authors:  Edvard Wigren; Jean-Marie Bourhis; Inari Kursula; Jodie E Guy; Ylva Lindqvist
Journal:  FEBS Lett       Date:  2010-02-09       Impact factor: 4.124

7.  High-resolution calcium mapping of the endoplasmic reticulum-Golgi-exocytic membrane system. Electron energy loss imaging analysis of quick frozen-freeze dried PC12 cells.

Authors:  R Pezzati; M Bossi; P Podini; J Meldolesi; F Grohovaz
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

8.  Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency.

Authors:  Beat Nyfeler; Yukiko Kamiya; Françoise Boehlen; Kazuo Yamamoto; Koichi Kato; Philippe de Moerloose; Hans-Peter Hauri; Marguerite Neerman-Arbez
Journal:  Blood       Date:  2007-10-30       Impact factor: 22.113

9.  [Congenital factor V deficiency (parahemophilia) with true hemophilia in two brothers].

Authors:  J OERI; M MATTER; H ISENSCHMID; F HAUSER; F KOLLER
Journal:  Bibl Paediatr       Date:  1954

10.  Transcriptional regulation of rod photoreceptor homeostasis revealed by in vivo NRL targetome analysis.

Authors:  Hong Hao; Douglas S Kim; Bernward Klocke; Kory R Johnson; Kairong Cui; Norimoto Gotoh; Chongzhi Zang; Janina Gregorski; Linn Gieser; Weiqun Peng; Yang Fann; Martin Seifert; Keji Zhao; Anand Swaroop
Journal:  PLoS Genet       Date:  2012-04-12       Impact factor: 5.917

View more
  12 in total

1.  Analysis of MCFD2- and LMAN1-deficient mice demonstrates distinct functions in vivo.

Authors:  Min Zhu; Chunlei Zheng; Wei Wei; Lesley Everett; David Ginsburg; Bin Zhang
Journal:  Blood Adv       Date:  2018-05-08

2.  Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy.

Authors:  Angiola Rocino; Antonio Coppola; Massimo Franchini; Giancarlo Castaman; Cristina Santoro; Ezio Zanon; Elena Santagostino; Massimo Morfini
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

3.  Recurrent Ruptured Hemorrhagic Corpus Luteal Cyst in a Known Case of Combined Deficiency of Factor V and VIII.

Authors:  Shruthi Kesireddy
Journal:  J Obstet Gynaecol India       Date:  2017-06-23

4.  LMAN1 (ERGIC-53) promotes trafficking of neuroreceptors.

Authors:  Yan-Lin Fu; Bin Zhang; Ting-Wei Mu
Journal:  Biochem Biophys Res Commun       Date:  2019-02-18       Impact factor: 3.575

5.  Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations.

Authors:  Luis Javier Serrano; Mariano Garcia-Arranz; Juan A De Pablo-Moreno; José Carlos Segovia; Rocío Olivera-Salazar; Damián Garcia-Olmo; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

6.  Solving the Measurement Problem and then Steppin' Out over the Line Riding the Rarest Italian: Crossing the Streams to Retrieve Stable Bioactivity in Majorana Bound States of Dialy zed Human Platelet Lysates.

Authors:  Mark Roedersheimer
Journal:  Open Neurol J       Date:  2015-06-26

Review 7.  Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders.

Authors:  Giancarlo Castaman; Silvia Linari
Journal:  J Clin Med       Date:  2017-04-10       Impact factor: 4.241

8.  The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.

Authors:  Magdalena Gierula; Isabelle I Salles-Crawley; Salvatore Santamaria; Adrienn Teraz-Orosz; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  J Thromb Haemost       Date:  2019-08-09       Impact factor: 5.824

9.  Familial Multiple Coagulation Factor Deficiencies (FMCFDs) in a Large Cohort of Patients-A Single-Center Experience in Genetic Diagnosis.

Authors:  Barbara Preisler; Behnaz Pezeshkpoor; Atanas Banchev; Ronald Fischer; Barbara Zieger; Ute Scholz; Heiko Rühl; Bettina Kemkes-Matthes; Ursula Schmitt; Antje Redlich; Sule Unal; Hans-Jürgen Laws; Martin Olivieri; Johannes Oldenburg; Anna Pavlova
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

10.  Altered phenotype in LMAN1-deficient mice with low levels of residual LMAN1 expression.

Authors:  Lesley A Everett; Rami N Khoriaty; Bin Zhang; David Ginsburg
Journal:  Blood Adv       Date:  2020-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.